SABS SAB Biotherapeutics Inc. Net earnings per share growth forecast for next year
SAB Biotherapeutics is strengthening its position through partnerships with US government agencies to develop antibodies. The historical trend of next year's EPS forecast confirms this trajectory, while 38.40 shows the current value of the metric. The business relies on transgenic cows for accelerated drug synthesis, although a high dependency on diabetes treatment success creates certain technological risks.
Analytical breakdowns and data insights for company sabbiotherapeutics.com (SABS)
- stock quotes and analyst forecast:
- market capitalization data:
- company book value details:
- debt obligations and liquidity statistics:
Total Debt to Capital SAB Biotherapeutics|SABS - Long-Term Debt to Capital|Short-Term Debt to Capital SAB Biotherapeutics, Inc.|SABS - Company Debts|Debt to Book Value SAB Biotherapeutics|SABS - Company Long-Term Loans and Borrowings|Company Short-Term Debts SAB Biotherapeutics|Quick Ratio sabbiotherapeutics.com
- earnings and valuation multiples information:
SABS - Net Financial Result|Expected Profit SAB Biotherapeutics|SABS - Market Cap to Earnings|Projected Price to Earnings SAB Biotherapeutics|SABS - Company Value to Earnings Growth Ratio|EV/EBITDA Multiple SAB Biotherapeutics|SABS - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) SAB Biotherapeutics|SABS - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months sabbiotherapeutics.com|SABS - Earnings per share increase in current year|Earnings growth forecast for next year SAB Biotherapeutics
- total revenue and sales volume data:
Summary company analysis:SAB Biotherapeutics, Inc
SAB Biotherapeutics is expanding the production of immunobiological drugs by integrating strict ESG standards and bioethics into its operational processes. The expected EPS growth for the coming year reflects consolidated analyst forecasts for net income changes, filtering out market noise to identify a sustainable trend. This indicator measures the business's sensitivity to external shocks, allowing investors to promptly assess the company's fundamental value without time lags.
Competitor analysis for SAB Biotherapeutics
Expected earnings per share growth for next year ARGX|Earnings growth forecast for next year BioNTech Pharma|Net earnings per share growth forecast for next year Abivax (ABVX)|admabiologics.com - Projected earnings per share growth rate for next year|Earnings growth forecast for next year PTGX (Protagonist)|Immunovant Inc (IMVT) - Expected net earnings per share growth next year|KNSA - Net earnings per share growth forecast for next year|Consensus forecast of earnings per share growth for next year Grifols Biemat GRFS|ADPT: Earnings growth forecast for next year|celldex.com (CLDX) - Earnings growth forecast for next year|AUPH (Aurinia Pharmaceuticals Inc.) - Earnings growth forecast for next year|Net earnings per share growth forecast for next year BCRX|Expected earnings per share growth for next year VERA (Vera Pharma)|DNTH (Dianthus Corp) - Expected earnings per share trend next year|Earnings growth forecast for next year PHVS (Pharvaris N.V.)|abcellera.com - Net earnings per share growth forecast for next year|Tourmaline Bio - Earnings growth forecast for next year|Consensus forecast of earnings per share growth for next year Precigen Inc PGEN|Pharming (PHAR) - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year Nektar Corp (NKTR)|Expected earnings per share growth for next year UPB|ZBIO (zenasbio.com) - Projected earnings per share increase next year|Earnings growth forecast for next year IMNM|GOSS (Gossamer Bio Inc) - Expected earnings per share trend next year|Earnings growth forecast for next year KALV (KalVista Pharmaceuticals Inc)|Septerna Pharma (SEPN) - Expected net earnings per share growth next year|PVLA - Net earnings per share growth forecast for next year|Expected earnings per share trend next year SVRA (savarapharma.com)|RIGL: Earnings growth forecast for next year|AnaptysBio Inc (ANAB) - Earnings growth forecast for next year|Net earnings per share growth forecast for next year Astria Pharma|enGene Corp - Net earnings per share change forecast for next year|Earnings growth forecast for next year RAPT|JBIO - Expected net earnings per share growth next year|Aclaris Therapeutics, Inc. - Expected earnings per share growth for next year|Earnings growth forecast for next year Kyverna Therapeutics Inc. KYTX|TLSA: Expected earnings per share growth for next year|Cabaletta Bio Inc - Projected earnings per share increase next year|VTYX: Earnings growth forecast for next year|THTX - Consensus forecast of earnings per share growth for next year|AVTX (Avalo Therapeutics) - Earnings growth forecast for next year|Expected earnings per share growth for next year Eledon Pharmaceuticals Inc. (ELDN)|Net earnings per share growth forecast for next year Agenus Inc (AGEN)|Consensus forecast of earnings per share growth for next year Climb Bio, Inc|Net earnings per share growth forecast for next year Zura Bio Limited ZURA|Consensus forecast of earnings per share growth for next year atyrpharma.com (ATYR)|Adagene Corp - Earnings growth forecast for next year|IMA - Earnings growth forecast for next year|STTK: Earnings growth forecast for next year|EQ (Equillium) - Net earnings per share growth forecast for next year|Net earnings per share growth forecast for next year Connect Biopharma Holdings|Immunic Inc (IMUX) - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Atara Biotherapeutics (ATRA)|IFRX: Net earnings per share change forecast for next year|Earnings growth forecast for next year XFOR (X4 Pharma)|Expected earnings per share trend next year ACET|Celularity Corp - Earnings growth forecast for next year|INMB - Earnings growth forecast for next year|Barinthus Biotherapeutics plc (BRNS) - Net earnings per share growth forecast for next year|Kezar Life Sciences Inc. - Expected earnings per share trend next year|Net earnings per share growth forecast for next year Akari Therapeutics plc|Expected earnings per share growth for next year Enlivex Therapeutics, Ltd. (ENLV)|Earnings growth forecast for next year QTTB|Earnings growth forecast for next year geovax.com (GOVX)|Edesa Biotech - Expected earnings per share growth for next year|Expected earnings per share trend next year IBIO|Carisma Tx - Earnings growth forecast for next year|Consensus forecast of earnings per share growth for next year XTL Bio XTLB|boltbio.com (BOLT) - Net earnings per share growth forecast for next year|Expected earnings per share growth for next year HCW Biologics|Net earnings per share growth forecast for next year Aptevo Therapeutics, Inc.|Expected earnings per share growth for next year AIM ImmunoTech, Inc. (AIM)|Expected earnings per share growth for next year ADTX (Aditxt)|Earnings growth forecast for next year GRI Bio Corporation (GRI)|Net earnings per share growth forecast for next year XORTX Therapeutics Inc. XRTX|HIND: Projected earnings per share growth rate for next year|Revelation Biosciences, Inc. - Earnings growth forecast for next year|Expected net earnings per share growth next year Indaptus Therapeutics Inc|Scinai (SCNI) - Net earnings per share growth forecast for next year|CALI - Consensus forecast of earnings per share growth for next year|AFMD (Affimed NV) - Earnings growth forecast for next year|Earnings growth forecast for next year Allakos Therapeutics|Earnings growth forecast for next year HOOK|Net earnings per share growth forecast for next year IGMS (igmbio.com)|iTeos - Expected earnings per share growth for next year|Expected earnings per share trend next year OCEA|TC Biopharm - Earnings growth forecast for next year|THRD: Net earnings per share growth forecast for next year
